Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Research
Biotech
Clinical Data
Venture Capital
Deals
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Cell & Gene Therapy
COVID-19
Podcasts
Resources
Events
Webinars
Podcasts
Whitepapers
Subscribe
What are you searching for?
Enclose phrases in quotes. Use a + to require a term in results and - to exclude terms.
Example: +water -Europe
Subscribe
Research
Biotech
Clinical Data
Venture Capital
Deals
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Cell & Gene Therapy
COVID-19
Podcasts
Resources
Events
Webinars
Podcasts
Whitepapers
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Ocugen
Biotech
Ocugen COVID shot will have to wait for US market after FDA hold
Ocugen revealed in the early morning hours after Thanksgiving that the FDA placed a clinical hold on its COVID-19 vaccine.
Kyle LaHucik
Nov 29, 2021 11:27am
Ocugen climbs on phase 3 COVID vaccine data
Jul 6, 2021 9:30am
Ocugen preps dry eye disease drug for phase 3
Mar 20, 2018 10:18am
Aeterna review, Allegro eye test and Ocugen orphan tag—News of Note
Aug 9, 2017 9:46am
Chutes & Ladders—BIO elects John Maraganore as new chair
Jun 22, 2017 4:08pm
Eye specialist Ocugen looks east for second-round fundraising
Jun 15, 2017 9:42am